Jacobs Levy Equity Management’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-184,724
| Closed | -$920K | – | 1139 |
|
|
2018
Q2 | $920K | Buy |
184,724
+147,904
| +402% | +$737K | 0.01% | 683 |
|
|
2018
Q1 | $144K | Sell |
36,820
-50,028
| -58% | -$196K | ﹤0.01% | 958 |
|
|
2017
Q4 | $233K | Buy |
86,848
+16,328
| +23% | +$43.8K | ﹤0.01% | 875 |
|
|
2017
Q3 | $225K | Buy |
70,520
+26,800
| +61% | +$85.5K | ﹤0.01% | 838 |
|
|
2017
Q2 | $145K | Buy |
43,720
+11,483
| +36% | +$38.1K | ﹤0.01% | 875 |
|
|
2017
Q1 | $135K | Sell |
32,237
-2
| -0% | -$8 | ﹤0.01% | 836 |
|
|
2016
Q4 | $131K | Sell |
32,239
-59,681
| -65% | -$243K | ﹤0.01% | 872 |
|
|
2016
Q3 | $344K | Sell |
91,920
-24,970
| -21% | -$93.4K | 0.01% | 781 |
|
|
2016
Q2 | $397K | Buy |
+116,890
| New | +$397K | 0.01% | 817 |
|
|
2015
Q4 | – | Sell |
-4,680
| Closed | -$68K | – | 943 |
|
|
2015
Q3 | $68K | Sell |
4,680
-10,210
| -69% | -$148K | ﹤0.01% | 782 |
|
|
2015
Q2 | $290K | Buy |
14,890
+2,070
| +16% | +$40.3K | 0.01% | 665 |
|
|
2015
Q1 | $232K | Buy |
12,820
+1,670
| +15% | +$30.2K | ﹤0.01% | 679 |
|
|
2014
Q4 | $263K | Buy |
+11,150
| New | +$263K | ﹤0.01% | 708 |
|
|
2014
Q2 | – | Sell |
-1,340
| Closed | -$46K | – | 1038 |
|
|
2014
Q1 | $46K | Hold |
1,340
| – | – | ﹤0.01% | 873 |
|
|
2013
Q4 | $26K | Sell |
1,340
-25,558
| -95% | -$496K | ﹤0.01% | 932 |
|
|
2013
Q3 | $436K | Sell |
26,898
-67,469
| -71% | -$1.09M | 0.01% | 726 |
|
|
2013
Q2 | $991K | Buy |
+94,367
| New | +$991K | 0.02% | 576 |
|